Cytotoxicity of naphthoquinones toward cultured resting murine leukemia L1210 cells in the presence of glutathione, diethyl maleate, or iodoacetamide

Biological and Pharmaceutical Bulletin

Volumn 20, Issue 12, 1997, Pages 1250-1256

  Noda, Yasuhiro ^a   Kawazoe, Yutaka ^a   Hakura, Atsushi ^b  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b EISAI CO LTD   (Japan)

Author keywords

Cytotoxicity; Diethyl maleate; Glutathione; Iodoacetamide; Naphthoquinone

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; ANTINEOPLASTIC AGENT; DOXORUBICIN; IODOACETAMIDE; MALEIC ACID DIETHYL ESTER; MITOMYCIN C; PARAQUAT;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOPATHOGENIC EFFECT; DRUG CONFORMATION; DRUG EFFECT; DRUG POTENTIATION; ELECTRON TRANSPORT; LEUKEMIA CELL; MOUSE; MURINE LEUKEMIA; NONHUMAN; STRUCTURE ACTIVITY RELATION;

EID: 0031455238     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.20.1250     Document Type: Article

References (31)

1. Noda Y., Shimizu N., Kawazoe Y., Biol. Pharm. Bull., 19, 1565-1569 (1996).
2. Noda Y., Kaiya T., Kohda K., Kawazoe Y., Chem. Pharm. Bull., 45, 1665-1670 (1997).
3. O'Brien P, J., Chem.-Biol. Interact., 80, 1-41 (1991).
4. Hakura A., Mochida H., Tsutsui Y., Yamatsu K., Chem. Res. Toxicol., 7, 559-567 (1994).
5. Smith T. H., Wu H., J. Org. Chem., 47, 1974-1976 (1982).
6. Smith L.I.,Webster I.M., J. Am. Chem. Soc., 59, 662-665 (1963).
7. Gant T. W., Ramakrishna R. D. N., Mason R. P., Cohen G. M., Chem.-Biol. Interact., 65, 157-173 (1988).
8. Reynolds G. A., Van Allan J. A., J. Am. Chem. Soc., 29, 3591-3593 (1964).
9. Cameron D. W., Deutscher D. J., Feutrill G. F., Griffiths P. G., Aust. J. Chem., 34, 2401-2404 (1981).
10. Chou T. C., Talalay P., Adv. Enzyme Regul., 22, 27-55 (1984).
11. Sakai S., Boutyuu Kagaku, 32, 79-92 (1967).
12. Bhuyan B. K., Fraser T. J., Day K. J., Cancer Res., 37, 1057-1063 (1977).
13. Shimizu N., Wu W., Kohara A., Kohda K., Suzuki T., Kawazoe Y., Biol. Pharm. Bull., 20, 168-170 (1997); and references cited therein.
14. Ollinger K., Brunmark A., J. Biol. Chem., 266, 21496-21503 (1991).
15. Doherty M. d'A., Rodgers A., Cohen G. M., J. Appl ToxicoL ., 7, 23-129 (1987).
16. Farrington J. A., Ebert M., Land E. J., Fletcher K., Biochim. Biophys. Acta. 314, 372-381 (1973).
17. Hassan H. M., Fridovich I., J. Biol. Chem., 254, 10846-10852 (1979).
18. Plummer J. L., Smith B. R., Sies H., Bend J. R., Methods Enzymol., 77, 50-59 (1981).
19. Honda S., Matsuo M., Biochem. International 18, 439-446 (1989); and reference cited therein.
20. Martin Y. C., "Quantitative Drug Design: A Critical Introduction," Table of Appendix II, Marcel Dekker, Inc., New York, 1978.
21. Stewart J. J. P., JCPE PO81, JCPE Newsletter, 6, 76 (1995).
22. Stewart J. J. P., J. Comput. Chem., 10, 209 (1989).
23. Buffinton G. D., Oellinger K., Brunmark A., Cadenas E., Biochem. J., 257, 561-571 (1989).
24. van Zyl J. M., van der Walt B. J., Kregler A., Horm. Metab. Res., 25, 569-572 (1993).
25. Awasthi Y. C., Beultat E., Srivastava S. K., J. Biol Chem., 250, 5144-5149 (1975).
26. Zakowski J. J., Tappel A. L., Biochem. Biophys. Acta. 526, 65-76 (1978).
27. Bell I. M., Fisher M. L., Wu Z.-P., Hilvert D., Biochemistry, 32, 3754-3762 (1993)
28. Westendorf J., Marquardt H., Marquardt H., Cancer Res., 44, 5599-5604 (1984).
29. Bhuyan B. K., Zimmer D. M., Mazurek J. H., Trzos R.J., Harbach P. R., Shu V. S., Johnson M. A., Cancer Res., 43, 5293-5297 (1983).
30. Lyer V. N., Szyboski W., Science, 145, 55-58 (1964).
31. Tomasz M., Lipman R., Snyder J. K., Nakanishi K., J. Am. Chem. Soc., 105, 2059-2063 (1983).